Correlation Between NYSE Composite and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on NYSE Composite and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Dermata Therapeutics.
Diversification Opportunities for NYSE Composite and Dermata Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between NYSE and Dermata is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Dermata Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 27.22 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 44.01 times less risky than Dermata Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 0.83 in Dermata Therapeutics Warrant on August 28, 2024 and sell it today you would earn a total of 0.05 from holding Dermata Therapeutics Warrant or generate 6.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 27.27% |
| Values | Daily Returns |
NYSE Composite vs. Dermata Therapeutics Warrant
Performance |
| Timeline |
NYSE Composite and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Dermata Therapeutics Warrant
Pair trading matchups for Dermata Therapeutics
Pair Trading with NYSE Composite and Dermata Therapeutics
The main advantage of trading using opposite NYSE Composite and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| NYSE Composite vs. Vita Coco | NYSE Composite vs. Franklin Wireless Corp | NYSE Composite vs. Ambev SA ADR | NYSE Composite vs. Toro Co |
| Dermata Therapeutics vs. Eliem Therapeutics | Dermata Therapeutics vs. Scpharmaceuticals | Dermata Therapeutics vs. Milestone Pharmaceuticals | Dermata Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |